News

Following positive results from a pivotal Phase III trial assessing the safety and efficacy of sutimlimab in people with primary cold agglutinin disease (CAD), Sanofi is making plans to seek regulatory approval of the medication in the United States. France-based...

The Pistoia Alliance, a global, not-for-profit organisation that works to lower barriers to innovation in life sciences R&D, announced the publication of a new report into the future of the life science and healthcare industries: ‘2030: Life sciences and...

Onconova Therapeutics, Inc , a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), and Inceptua Medicines Access (a business unit of the Inceptua Group), a global pharmaceutical...

Abzena is showcasing its new Developability Service, enabling biotechnology and pharmaceutical companies to improve lead selection and de-risk cell line development, at Antibody Engineering & Therapeutics 2019 being held 9–13 December, on Booth #414 at the Marriott Marquis San...

Connectivity, customization and sustainability are driving pharmaceutical packaging and drug delivery innovation at Pharmapack Europe (#pharmapackeu), which opens in February 2020. The event is the leading exhibition dedicated to pharmaceutical packaging and drug delivery devices, with major industry players...

Bora, a contract development and manufacturing organization (CDMO) which specializes in modified release and solvent production, has announced the appointment of Samuel Ricchezza as President of North America Operations. Bringing over 25 years’ CDMO experience to the team, Ricchezza is...

European speciality pharmaceutical company Neuraxpharm Group has announced the launch of Neuraxpharm Portugal as part of an expansion of its operations in Southern Europe. Neuraxpharm Portugal will be based in Lisbon and be part of the Southern European Region, which...